Literature DB >> 7967907

Differentiation between Crohn's disease and ulcerative colitis.

C P Ogorek1, R S Fisher.   

Abstract

In the last several decades, the incidence of CD has been rising. This trend in part has been due to the clinical recognition of isolated CD. The differentiation can usually be made based on careful clinical history, physical examination, and diagnostic testing. The most reliable, sensitive method for differentiating these two diagnoses is colonoscopy. The ability to obtain directed endoscopic colonic biopsy specimens gives an even greater diagnostic yield. In many situations, observation of the clinical course and repeated diagnostic evaluations result in further clarification of the disease process involved. The importance of establishing an accurate diagnosis becomes most relevant when surgery is indicated. Once surgery has been performed, evidence of recurrent disease at the site of an ileostomy, ileal pouch, or ileorectal anastomosis establishes the disease as CD. In the absence of recurrent disease after colectomy, the difference becomes one of academic interest.

Entities:  

Mesh:

Year:  1994        PMID: 7967907     DOI: 10.1016/s0025-7125(16)30098-0

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  2 in total

Review 1.  Infliximab treatment for Crohn's disease.

Authors:  C A Conroy; R Cattell
Journal:  Postgrad Med J       Date:  2001-07       Impact factor: 2.401

2.  In vivo pharmacokinetic study for the assessment of poly(L-aspartic acid) as a drug carrier for colon-specific drug delivery.

Authors:  C S Leopold; D R Friend
Journal:  J Pharmacokinet Biopharm       Date:  1995-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.